Plantar Fasciitis Treatment Market Intelligence Report Covers Trends, Segments And Regional Growth

The plantar fasciitis treatment market is poised for remarkable expansion as new technologies and treatment methods gain traction. Driven by advancements in diagnostics, personalized care, and non-invasive therapies, this sector is set to experience rapid growth over the next several years. Below, we explore the market's projected size, key players, emerging trends, and segment insights that are shaping its future.

Projected Market Size and Growth Trajectory of the Plantar Fasciitis Treatment Market
The plantar fasciitis treatment market is anticipated to surge substantially, reaching a valuation of $5.69 billion by 2030. This impressive growth corresponds to a compound annual growth rate (CAGR) of 22.2%. Factors fueling this expansion include wider adoption of sophisticated diagnostic imaging techniques, heightened demand for customized orthotic products, and an increase in outpatient orthopedic services. Additionally, the growing emphasis on preventive care for musculoskeletal health and the integration of physical therapy into treatment plans further support the market's upward trend. Important trends expected during the forecast period include a shift toward non-invasive therapies, extensive use of shockwave and physical therapy treatments, expansion of multidisciplinary foot care approaches, and a growing focus on early diagnosis coupled with conservative management.

The plantar fasciitis treatment market size has grown exponentially in recent years. It will grow from $2.07 billion in 2025 to $2.55 billion in 2026 at a compound annual growth rate (CAGR) of 23.1%. The growth in the historic period can be attributed to increasing prevalence of foot and heel pain disorders, rising incidence of obesity-related foot conditions, growing participation in sports activities, improved availability of physical therapy services, expansion of orthopedic care facilities.

Download a free sample of the plantar fasciitis treatment market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9385&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Players Driving Innovation and Market Presence in Plantar Fasciitis Treatment
Several prominent companies hold significant positions within the plantar fasciitis treatment field. These include Bayer AG, Superfeet Worldwide LLC, Bauerfeind AG, Ottobock SE & Co. KGaA, Sanofi SA, Eli Lilly and Company, GlaxoSmithKline plc, Pfizer Inc., Bristol-Myers Squibb Company, Scholl's Wellness Co., Hanger Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Smith & Nephew plc, Arthrex Inc., DJO Global Co., Medline Industries Inc., Bird & Cronin Inc., Aetrex Worldwide Inc., Zimmer Biomet Holdings Inc., Stryker Corporation, Breg Inc., TheraBand LLC, and Foot Levelers Inc.
A notable development occurred in September 2024 when Bansk Group, a US-based investment firm, acquired Foundation Wellness for an undisclosed amount. This strategic move aims to bolster Bansk Group's plantar fasciitis portfolio by incorporating Foundation Wellness's specialized orthotics, insoles, and foot-care products designed to alleviate foot pain and other related conditions.

Emerging Technological Trends Transforming the Plantar Fasciitis Treatment Industry
Innovations in wearable medical devices are playing a critical role in the evolution of plantar fasciitis treatment. Many companies are focusing on developing wearable, long-duration ultrasound devices that provide at-home soft-tissue therapy. These devices help promote healing, reduce pain, and potentially decrease the need for invasive procedures by delivering continuous low-intensity ultrasonic energy to affected areas. This energy enhances blood flow, oxygen delivery, and cellular repair, offering a non-invasive alternative to traditional treatments like orthotics, pain medications, or corticosteroid injections.
For example, in June 2025, ZetrOZ Systems, a US-based medical device manufacturer, unveiled the sam 2.0, an advanced wearable ultrasound therapy device specifically designed for plantar fasciitis. This product offers multi-hour sessions of low-intensity ultrasound that encourages collagen formation, speeds up soft-tissue repair, diminishes inflammation, and can be conveniently self-administered at home. This innovation provides patients with a drug-free, non-surgical treatment option that adds convenience and efficacy.

View the full plantar fasciitis treatment market report:
https://www.thebusinessresearchcompany.com/report/plantar-fasciitis-treatment-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Breakdown of Major Segments in the Plantar Fasciitis Treatment Market
The plantar fasciitis treatment market is categorized into several key segments to better understand its structure and growth opportunities:
1) By Type: Medication Therapy, Orthotics, Shockwave Therapy, Surgery, and Other Types
2) By Diagnosis Method: Medical History, Physical Examination, X-Rays, Radiography, and Other Diagnosis Techniques
3) By End User: Hospitals, Clinics, and Other End User Categories
Further segmentation under Medication Therapy includes Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Pain Relievers, and Topical Treatments. The Orthotics category is subdivided into Custom Orthotic Inserts, Over-The-Counter Insoles, Night Splints, and Heel Cups. Shockwave Therapy features both Radial and Focused Shockwave types. Surgical interventions cover Plantar Fascia Release, Gastrocnemius Recession, and other procedures. Lastly, Other Types encompass physical therapy, massage therapy, stretching and strengthening exercises, and alternative therapies.

The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.